Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9312
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 194 $2,837,415 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $2,837,415 Current and potential, with all options
- Last date to order 84% complete
- IDV ceiling 57% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is planning to issue a solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to establish multiple firm-fixed-price, requirements-type contracts for worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, United States Coast Guard, and US Naval Fleet. The estimated total value of the contract is $30.3 billion over a 30-month base period and three 30-month option periods. The contracts will cover a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support normal operations as well as planned and unplanned contingencies. The Government intends to make multiple primary supplier awards for separate regions (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet) and one award for a backup supplier across all regions. Awards will be made on a lowest price technically acceptable basis, with the option to use reverse auctions to obtain the best distribution fees. The prime contractor, DMS Pharmaceutical Group Inc., is a woman-owned small business that currently holds a significant single-award Indefinite Delivery Contract with DLA valued at $499,999,999.
Task orders
Show 40 more
Latest 50 of 194 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D9312?
SPE2DR25D9312 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D9312 worth?
Orders under SPE2DR25D9312 have obligated $2,837,415. SPE2DR25D9312's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9312?
194 orders have been placed under SPE2DR25D9312, the latest on July 28, 2026.
Who can order from contract SPE2DR25D9312?
SPE2DR25D9312 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9312 competed?
The extent of competition for SPE2DR25D9312 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV